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Increasing age typically results in a decreased skeletal muscle regenerative capacity after injury, a 
decreased muscle mass and weakness, ultimately resulting in an increased likelihood for falls, 
susceptibility to recurrent injury, and a prolonged recovery. In response to injury, aged muscle 
displays a decreased capacity to regenerate damaged myofibers. Instead, the repair response is 
characterized by fibrotic accumulation, a response that has been attributed to dysfunction of the 
muscle stem cell (MuSC) population. MuSCs are a reserve cell population that plays a central role 
in dictating muscle regeneration. Muscle contractile activity, elicited by exercise or electrical 
stimulation, for example, has been suggested to be an important intervention to increase blood flow 
to the injury area and to promote the activation of muscle MuSCs. The purpose of this study is to 
test the hypothesis that neuromuscular electrical stimulation (Estim) inhibits activation of the 
muscle progenitor cell (MPC) fibrogenic molecular program to enhance skeletal muscle 
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regeneration in aged animals. MPCs represent a heterogenous myogenic cell population, the 
majority of which are MuSCs. Our in vivo studies demonstrate that two weeks of Estim enhances 
myofiber regeneration and increases tetanic force recovery in aged muscles after an acute injury. In 
vitro, we find that improved muscle regeneration in aged muscle following the application of Estim 
is concomitant with a rejuvenated MPC phenotype. Our results further suggest that the beneficial 
effect of Estim on MPC regenerative potential may be mediated by up-regulation of the anti-aging 
protein, Klotho. Taken together, these data provide evidence that Estim is a safe and effective 
method and to improve functional recovery after an acute injury in aged muscle.  It is anticipated 
that findings from this study will aid in the development of clinically relevant rehabilitation 
programs to enhance the muscle healing response in a geriatric population. 
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1.0  INTRODUCTION 
1.1 STATEMENT OF THE PROBLEM 
Age-related skeletal muscle weakness and impairment in regenerative capacity following injury is 
a major contributor to declines in functional mobility and is associated with an increased morbidity 
in an elderly population (1-4).  Muscle wasting and weakness resulting from sarcopenia can 
increase the risk for subsequent injury, leading to dramatic declines in mobility that may ultimately 
deprive a person of functional independence (1, 5). In addition to sarcopenia—an age-related 
decrease in skeletal muscle mass—the capability of skeletal muscle to repair itself after injury is 
typically impaired, and functional recovery is often impeded by fibrotic tissue formation (1). As 
the number of elderly individuals in the United States grows at an escalating rate, such detriments 
increasingly represent an important public health burden. For an elderly individual who is already 
weak, a failed regenerative response following an injury may mean the difference between 
independence and going to a nursing home.  
Age-related impairment- and functional-level declines are a clear manifestation of 
underlying tissue and cellular dysfunction. After muscle injury, muscle stem (satellite) cells 
(MuSCs) exit their normally quiescent state, proliferate, and fuse to form new myofibers. 
However, there is a decline in the activation, proliferation, and differentiation of MuSCs over time 
(6-8).  
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An increased understanding of the cellular signaling pathways responsible for regenerative 
decline in aged muscle is of considerable interest toward the development of clinical programs 
designed to counteract the effect of age on skeletal muscle healing capacity.  
Recent studies have demonstrated that MuSC behavior, and, ultimately, skeletal muscle 
regenerative capacity is largely dependent on characteristics of the microenvironment, or niche. 
Data from in vitro studies have demonstrated that, when MuSCs are isolated from aged muscle 
and cultured in serum obtained from young animals, MuSCs demonstrate an enhanced 
myogenicity (9). Conversely, when MuSCs isolated from young muscle are cultured in the 
presence of serum derived from aged animals, MuSCs demonstrate an increased fibrogenic fate 
(10). These data suggest that systemic factors play an important role in the functional capacity of 
MuSCs, further implicating the microenvironment as a target for the development of approaches 
to enhance aged muscle regeneration.  
Modulation of the microenvironment through muscle loading—via endurance exercise 
training, for example—has been shown to be beneficial for skeletal muscle adaptations such as 
changes in muscle fiber type and fiber area, angiogenesis, and the secretion of myogenically 
favorable growth factors (11, 12). Evidence further suggests that mechanical stimuli via downhill 
treadmill running promotes MuSCs myogenicity and may be an effective and practical intervention 
strategy to prevent and/or reverse the cellular and molecular alterations associated with impaired 
repair of aged muscle (13). However, little is known about the ability of muscle contractile activity 
to reverse the effect of age on declines in muscle regenerative capacity. A better mechanistic 
understanding of how muscle loading may optimize MuSC functioning is an essential step in the 
development of rehabilitation approaches to prevent and/or improve muscle healing in aged 
population. 
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1.2 BACKGROUND 
1.2.1 Skeletal muscle regeneration 
Skeletal muscle injuries are a common problem in trauma and orthopedic surgery. In cases of 
relatively minor injuries, young healthy skeletal muscle possesses a great ability to fully recover 
the architecture and contractile function (14). The regeneration of skeletal muscle after injury 
comprises several coordinated and overlapping phases, including (1) degeneration, (2) 
inflammation, (3) regeneration and, finally, (4) fibrosis (15).  
 
 
The Degenerative Phase 
The degenerative phase of the muscle repair process starts in the first few days post-injury. 
It is characterized by disruption of sarcolemma, which results in an influx of calcium and cell death 
(10). Increased vascular permeability and blood flow results in hematoma formation and edema 
accumulation (16). Within a few hours after injury, inflammatory cells (leukocytes, monocyte-
lymphocyte, and macrophages) invade to the injury area. Macrophages initiate phagocytosis of the 
injured region, resulting in a “ghost-like” and “moth-eaten” appearance of the muscle fiber, (17). 
These ghost fibers are important to guide and recruit the regenerating cells into position (18). In 
addition, degrading myofibers become denervated through destruction of intramuscular nerve 
branches (19). 
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The Inflammatory Phase 
The inflammatory phase generally peaks within 24-48 hours after injury. During the 
inflammatory phase, macrophages and neutrophils are activated to eliminate the necrotic tissue 
and prepare the tissue for the regeneration phase. During this phase, growth factors are released, 
which affect the regenerative microenvironment and contribute to the symptomatology of muscle 
injuries, including pain and swelling (20). Inflammation is a critical step in the regenerative 
process, and studies have demonstrated that inhibition of the inflammatory phase, through non-
steroidal anti-inflammatory drugs (NSAIDs) administration, for example, dramatically impairs 
muscle-healing (20, 21).  Though studies using NSAIDS demonstrate a decrease in inflammation 
and pain shortly after muscle injury, investigators have observed long-term residual deficits in 
muscle functional capacity and muscle healing (21). Clearly, prostaglandins play a well-
established role in dictating MuSC proliferation and regenerative potential, and their inhibition is 
problematic for effective muscle healing (22, 23).  
It is hypothesized that the interruption of growth factor secretion associated with inhibition 
of inflammation, such as Insulin-like Growth Factor-1 (IGF-1), basic Fibroblast Growth Factor 
(bFGF), Hepatocyte Growth Factor (HGF), Epidermal Growth Factor (EGF), and Transforming 
Growth Factor Beta-1 (TGF-1), contributes to the regenerative defect following NSAIDs 
administration (20). However, supplementation with growth factors, including IGF-1, bFGF, and 
nerve growth factor (NGF) has been shown to dramatically enhance the healing process after 
muscle injury (24, 25). These growth factors have also been shown to play a critical role in 
regulating muscle stem cell (MuSC) proliferation and differentiation during regeneration (26) 
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The Regenerative Phase 
The regenerative phase is subsequently triggered by growth factor secretion. The primary 
cells regulating the skeletal muscle regenerative response are MuSCs. MuSCs are located between 
the basal lamina and the plasma membrane, and normally reside in a quiescent state (27)(Figure1). 
Upon activation, MuSCs enter a phase of proliferative expansion. A critical aspect of MuSC 
activation is that a portion of the activated MuSCs will return to a quiescent state, a process called 
“self renewal”. Self-renewal is critical for maintenance of the stem cell reservoir, such that a pool 
of stem cells is available for future rounds of regeneration. Another portion of the activated cells 
will fuse to the existing damaged myofibers, or will fuse to produce nascent myofibers. The 
regenerating myofiber is characterized by centralized nuclei, which eventually migrate to the 
myofiber periphery. The regenerative phase typically peaks within 2 weeks after injury, and then 
gradually decreases. 
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Figure 1. MuSC responses after myotrauma. 
 
The Fibrotic Phase 
In cases of severe injury or when the regeneration process fails, such as with disease or aging, the 
formation of fibrosis is initiated. Fibrosis serves to fill in the gap and minimize further injury to 
the tissue. Fibrosis generally begins between the second and third weeks post injury (15). Although 
this scar tissue provides early support for the injury area, it becomes progressively dense over time, 
and ultimately may restrict the formation of regenerating myofibers (16). Transforming Growth 
Factor Beta-1 (TGF-1) is considered to be a “master regulator” of fibrosis, and plays a role in the 
differentiation of myoblasts into a myofibroblast lineage (28). Several studies have demonstrated 
that inhibition of TGF-1 promotes an enhanced myofiber regeneration and muscle recovery (24, 
29, 30). Sato and colleagues demonstrated that a combination treatment of IGF-1 and Decorin (a 
TGF-1 antagonist), administered 1, 3, or 5 days post-laceration, improved both histological and 
contractile characteristics of skeletal muscle 4 weeks after injury (24). Another study demonstrated 
that scar tissue formation after muscle laceration was effectively inhibited with the use of Suramin, 
another TGF-1 inhibitor (31). These are just a few of the several existing studies demonstrating 
that inhibition of skeletal muscle fibrosis significantly improves functional regeneration after a 
severe muscle injury.   
 
Vascularization and reinnervation of injured muscle  
Most traumatic muscle injuries will also involve vascular and neural tissues. As such, the 
importance of restoration of these structures after an acute injury cannot be discounted. Both 
nerves and vessels have been shown to play a critical role in the regenerative cascade and 
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maturation of myotubes into myofibers (32). Nascent capillaries are necessary to provide adequate 
oxygen supply to area of injury area, subsequently supporting aerobic energy metabolism for the 
regenerating myofibers. Christov and colleagues (2007) observed a tight relationship between 
MuSCs and capillaries, and found that most resident MuSCs are juxtaposed with capillaries (33). 
In cases of myopathy, which display a decrease in myofiber capillarization, there is a concomitant 
decrease in the number of MuSCs per myofiber (34). Conversely, the skeletal muscle of healthy 
athletes displays an increased myofiber capillarization that is strongly correlated with an increased 
number of MuSCs (33).  
Finally, another important aspect of muscle regeneration is the myofiber reinnervation. 
Reinnervation is required both to prevent myofiber atrophy and restore functional capacity (15). 
Indeed, non-innervated regenerating fibers remain both functionally and histochemically immature 
(33). During regeneration, the neuromuscular junction is a tightly regulated and consists of two 
principal phases of repair. First, the ingrowth of nerves is stimulated by either outgrowth from the 
cut ends of nerves leading to the muscle, or by the sprouting of nerves into regenerating fibers 
(33). In the second phase, the regenerating nerves form functional neuromuscular junctions (33). 
Ingrowing nerve fibers have a strong predilection for settling down at the sites of previous 
neuromuscular junction (35).  
1.2.1.1 Aged-related declines in skeletal muscle regeneration 
Like most tissues, aging results in a dramatic decrease in skeletal muscle regenerative capacity, and 
the regenerative response becomes characterized by an increased fibrosis and adipose tissue 
accumulation (8). In addition, aging has been associated with a decrease in skeletal muscle 
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capillarity, owing, at least in part, to decreased expression of Vascular Endothelial Growth Factor 
(VEGF) levels, important for both for angiogenesis and for guiding MuSC responses (36).  
As described above, the ability of skeletal muscle to repair itself after injury is largely 
dependent on the action of MuSCs. However, with aging, a multitude of compromised MuSC 
responses ensue. Almost four decades ago, Snow (1977) observed a dramatic decrease in the 
number of MuSCs in aged skeletal muscle, when compared to young adult counterparts (37). This 
is consistent with more recent studies demonstrating that aged MuSCs demonstrate a dramatically 
decreased proliferative potential (38). In addition, MuSCs derived from aged skeletal muscle 
display a predisposition to differentiate toward a fibrogenic lineage, as opposed to the desirable 
myogenic cell fate (39). It is this myogenic-to-fibrogenic conversion that is hypothesized to 
underlie the increased fibrosis formation following injury in aged skeletal muscle. Taken together, 
these age-related alterations lead to a dramatically impaired regenerative capacity and functional 
recovery after a severe muscle injury (40). 
1.2.1.2 The molecular basis for age-related declines in skeletal muscle regeneration after 
injury 
Considerable progress was observed in the last decades in regards to our understanding of the 
molecular mechanisms underlying an age-related reduction in MuSCs function. There are many 
signaling pathways that have been implicated as playing major role in driving in age-related 
declines in muscle regenerative capacity. For example, Mitogen-Activated Protein Kinase (MAPK) 
is an important pathway that is stimulated in response to cytokines, growth factors, and cellular 
stress (41, 42). A recent study by Cosgrove et al (2014) demonstrated that aged MuSCs display an 
elevated p38α/β MAPK activity, but that small molecule inhibition of p38α/β MAPK inhibits 
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MuSCs senescence (33). Importantly, the beneficial effect of p38α/β MAPK inhibition was only 
observed when cells were cultured in a soft matrix substrate. These findings suggest that both 
biochemical and biophysical cues are important for defining MuSC behavior.  
Notch signaling, important for MuSCs activation, proliferation, and cell lineage 
specification, is another important pathway that has been shown to be dysregulated with increasing 
age. Decreased Notch activation contributes to the diminished regenerative capacity of aged muscle 
through an impaired MuSC proliferative capacity (8, 9). The progression of MuSCs from a phase 
of proliferative expansion to one of terminal differentiation is reliant on inhibition of the Notch 
signaling pathway by activation of the Wnt signaling pathway (33).  
Activation of the canonical Wnt signaling pathway has been suggested to be essential for 
dictating MuSC fate (43-45). The canonical Wnt signaling cascade is activated when soluble Wnt 
ligands interact with Frizzle receptors as well as low-density lipoprotein receptor-related protein 
co-receptors (LRP) at the cell surface. Frizzle receptor activation subsequently stimulates the 
phosphorylation of Disheveled and inactivates GSK3β phosphorylation of β-catenin. These events 
lead to inhibition of Axin-mediated β-catenin phosphorylation, leading to the stabilization of β-
catenin, which then accumulates and translocates to the nucleus to form complexes with TCF/LEF 
for the activation of Wnt target gene expression (Figure 2).  
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Figure 2. Canonical Wnt signaling pathway 
Schematic representation of the canonical Wnt/β-Catenin pathway. Off activation (left): In 
the absence of Wnt signal, β-Catenin is recruited into the APC/Axin2/GSK3 complex and 
phosphorylated by GSK3. As the result, β-Catenin is degraded, and β-Catenin fails to enter the 
nucleus. On Activation (right): Wnt binds the Frizzeled receptor and LRP co-receptor. Next, 
activated Disheveled leads to the inhibition of APC/Axin2/GSK3. Accumulated β-Catenin 
translocates to the nucleus and complexes with TCF/LEF, activating the canonical Wnt-target gene 
expression.  
 
Recently, Murphy and colleagues demonstrated that, though Wnt signaling/β-catenin pathway is 
active in amplifying myoblasts, silencing of this pathway is absolutely critical for effective 
regeneration (46). Accordingly, with aging, MuSCs demonstrate an excessive activation of the 
Wnt signaling pathway, which has been shown to ultimately result in a dysfunctional myogenic 
capability and enhanced fibrosis deposition at the injury site (7). The ligands contributing to this 
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increased Wnt signaling activation in aged muscle have yet to be elucidated, but are believed to be 
present in the circulation (47).  
1.2.1.3 Modulation of the microenvironment and its role in aged-related declines in muscle 
regeneration 
It is clear that the microenvironment, or niche, is a potent regulator of MuSC regenerative potential 
within skeletal muscle. The niche is necessary for the maintenance of MuSC quiescence and it 
provides critical support of tissue homeostasis and regenerative capacity (32). In addition, the 
niche includes vascular components that are important to deliver homeostatic signals to MuSCs, 
such as secreted molecules and cellular contacts (48). 
Indeed, modulation of microenvironment has the potential to dramatically alter the 
behavior of aged MuSCs. Studies have demonstrated that when aged MuSCs are exposed to a 
youthful microenvironment, regenerative potential is dramatically improved to levels comparable 
to young counterparts (7, 9). Moreover, this enhanced MuSC behavior is concomitant with an 
improved healing response (9, 39, 49). Carlson & Faulkner performed a series of experiments in 
which the extensor digitorum longus (EDL) muscle was heterochronically transplanted between 
young and old mice (ie. young muscle was transplanted into old hosts and old muscle was 
transplanted into young hosts) (49). The authors observed a significant improvement in contractile 
force and regeneration when old muscles were transplanted into young hosts (49). Conversely, both 
young and old muscles grafted in old hosts resulted in a dramatically decreased regeneration and 
force producing capacity of the transplanted muscle (33). Authors concluded that the poor 
regeneration of muscles in old animals may be related to an unsupportive microenvironment.  
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More recently, Brack et al demonstrated that MuSCs exposed in vitro to serum derived 
from young mice display a decreased Wnt signaling activation (as evidenced by an increased 
GSK3β, decreased Axin 2 and increased nuclear β-Catenin), as well as a concomitant increase in 
myogenic differentiation (7). Conversely, MuSCs exposed to old mouse serum display an increased 
Wnt signaling and increased fibrogenic conversion. The findings suggest that some serum 
component that is upregulated in the circulation of aged animals may be responsible for excessive 
Wnt signaling activation. Conversely, it is possible that some serum component found within young 
animals may be responsible for inhibition of the Wnt signaling cascade.   
Translating these in vitro findings to an in vivo model, investigators next turned to a 
heterochronic parabiotic approach (7). In this approach, aged animals are surgically joined with 
young animals, resulting in a chimeric circulatory system. Consistent with in vitro findings where 
aged MuSCs exposed to young serum display an enhanced myogenicity, in vivo studies 
demonstrated decreased fibrosis and improved myogenesis of aged heterochronic parabionts. 
Interestingly, exposure of aged mice to a young circulation was concomitant with an increased 
Notch signaling (49) and a decreased Wnt signaling activation (7). Findings were further confirmed 
by Wagers et al. who similarly demonstrated the ability of heterochronic parabiosis to improve 
muscle healing in aged mice (33). In their study, Wagers and colleagues suggested that the 
beneficial effect of exposure of aged mice to a youthful circulation was owing to the circulating 
protein Growth Differentiation Factor 11 (GDF11) (33). Specifically, they found that mice 
displayed a decrease in circulating GDF11 with increasing age, but that supplementation with 
GDF11 in aged mice resulted in significantly improved muscle structure after injury, as well as an 
improved capacity for endurance exercise (50). These findings were recently refuted by Egerman 
et al., who observed that GDF11, a part of the TGF-1 superfamily, actually increases in the 
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circulation of aged mice (51). Moreover, they found that GDF11 significantly inhibits MuSC 
proliferation and promotes fibrosis formation after injury (52).  
Despite the ongoing debate, it is clear that systemic factors play a critical role in supporting 
MuSC regenerative potential and skeletal muscle healing (7, 9). Though the circulating factor(s) 
responsible for mediating the beneficial effect of exposure to a youthful systemic environment is/are 
still unknown, heterochronic parabiosis studies confirm that MuSCs display downstream, 
autonomous alterations that support a rejuvenated phenotype in aged muscle. Elucidation of the 
circulating protein(s) that is (are) modulated through the aging process would, therefore, be a major 
advance toward the development of approaches to enhance skeletal muscle regenerative capacity 
in an aged population.  
 
1.2.2 Klotho as a mediator of tissue regeneration and stem cell functionality 
Klotho is circulating hormone that has been extensively investigated as playing an important role 
in regulating aged-declines. Klotho is an anti-aging protein predominantly produced in the kidney, 
but can be found small amounts in the brain, placenta, skeletal muscle, urinary bladder, aorta, 
colon, and pancreas (53-56). It serves as an aging suppressor protein through a variety of 
mechanisms, including anti-oxidation, anti-senescence, anti-autophagy, as well as modulation of 
signaling pathways associated with longevity, including Insulin Growth Factor (IGF) (53). Klotho 
has been found in the circulatory system of both animals and humans (57, 58), although it’s serum 
concentration gradually declines with increasing age (57, 58). Mice deficient for Klotho display 
premature aging, and die at proximally 8-9 weeks of age (the typical lifespan of wild type mice is 
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approximately 2.5-3 years) (54, 58). This decreased longevity is consistent with decreased physical 
activity, ectopic calcification, pulmonary emphysema, osteoporisis, atrophy of skin, intestine, 
lipodystrophy (54), impaired wound repair process (59), and chronic inflammation in many age-
related chronic disease, such as kidney disease, degenerative disease, diabetes, arteriosclerosis, 
skeletal muscle wasting, and hypertension (55, 60-64). Genetic up-regulation of Klotho, on the 
other hand, markedly delays age-related functional declines in various tissues and extends lifespan 
to levels ~31% greater than wild type counterparts (65, 66).  
Among the aged phenotypes associated with a decreased expression of Klotho is an 
impaired tissue healing response. A recent study by Liu and colleagues (2007) (58), reported that 
impaired skin and small intestinal regenerative response in Klotho knockout mice is associated 
with a decreased stem cell number, proliferation and resistance to stress, as well as an impaired 
angiogenesis (58). However, supplementation with Klotho rescues epithelial stem cell function to 
improve tissue repair and suppress fibrosis (67). Interestingly, Liu and colleagues (2007) observed 
that the Klotho protein binds to multiple Wnt ligands and inhibits the biological activity of Wnt 
proteins to enhance stem cell function (58). Do age-related declines in circulating Klotho similarly 
play a role in the fibrogenic conversion of MuSCs through a de-repression of Wnt signaling 
activation? 
1.2.3 Modulation of the skeletal muscle microenvironment through mechanical 
stimulation 
Exercise is a commonly implemented intervention to promote muscle repair in aged muscle and to 
stimulate the activation of molecular mechanisms critical for functional muscle repair (68), and 
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emerging evidence indicates that the application of mechanical stimuli increases MuSC activation 
and proliferation (69). Upon muscle loading, muscle produces chemical signals that may be 
essential for MuSC behavior and myogenicity (70). Studies have demonstrated that resistance 
training and treadmill exercise elevate MuSC numbers and increase myogenin (a transcription 
factor associated with myogenesis) levels in aged skeletal muscle (71-73). Mackey and 
collaborators (2007) reported that resistance training, performed 3 times a week for 12 weeks, was 
effective for enhancing the MuSC pool in the skeletal muscle of health elderly men and women 
(74). In addition, resistance training restores the proliferative capacity of MuSCs isolated from aged 
individuals to levels comparable to younger counterparts (75).  Similar results were found in a study 
by Dreyer et al, in which investigators demonstrated a significantly increased number of MuSCs 
within 24 hours after maximal eccentric knee extensor exercise in both young and older men, 
though the older men displayed an attenuated response (76). Accordingly, Shefer and colleagues 
(2010) observed a significant increase in the number of satellite cells/myofiber after completion of 
a running protocol (71). Importantly, mechanical loading upregulates the gene expression of 
angiogenic factors (77, 78), induces growth factor secretion (79), increases neural recruitment (33), 
increases blood flow and increases leukocyte and monocyte infiltration to the injury area (80), all 
of which are critical for adequate regeneration.  
Although, there are many studies demonstrating an increased number, activation, 
proliferation and differentiation of MuSCs, as well as an increased MuSC myogenicity and 
angiogenesis, the molecular mechanisms underlying these alterations remain poorly understood. 
One study suggested that application of a high-intensity exercise protocol to mice of varying 
different ages increases Wnt signaling activation in MuSCs (81, 82). Sakamoto and colleagues 
(2004) performed a study that included eight healthy human subjects. Subjects were submitted to 
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30 minutes of cycling exercise at both 75% of maximum intensity and 125% maximum intensity. 
Investigators found that exercise, both at submaximal and maximal intensities, deactivated GSK3 
and decreased phosphorylation of β-catenin in MuSCS (83). Another study by Armstrong and 
collaborators described that mechanical overloading of the plantaris muscle through bilateral 
synergist ablation significantly increased in Wnt/β-catenin pathway in plantaris muscle of young 
animals. Finally, Fujimaki et al. (2014) performed voluntary wheel running in adult and aging mice 
for 4 weeks and observed that voluntary wheel running induced the activation of canonical Wnt/β-
catenin signaling pathway. Unlike observations by Brack et al. (2007), in these cases, increased 
Wnt signaling was not associated with increased fibrosis formation, even in aged skeletal muscle 
(84). Taken together these data confirm that mechanical loading is a potent regulator of the Wnt/β-
catenin signaling pathway. However, the mechanisms underlying these effects remain unresolved.  
Recently, Avin and colleagues (2014) proposed the intriguing possibility that Klotho might 
be regulated in response to skeletal muscle contractile activity (85). Though a direct relationship 
between muscle activity and Klotho expression has never been investigated, a number of studies 
support the hypothesis that there is a tight relationship between skeletal muscle activity and Klotho 
expression (reviewed in (85)). Phelps and colleagues evaluated grip strength and running endurance 
between Klotho-deficient mice, transgenic Klotho overexpressing mice (EFmKL46), and wild-type 
control mice. They observed Klotho-deficient mice displayed ~50% less force, when compared to 
both Klotho overexpressing and wild-type control mice. Furthermore, Klotho deficient mice also 
presented ~60% less endurance capacity when compared to EFmKL46 and control mice (33). These 
murine observations have clinical correlates, and it has been shown through epidemiological studies 
that decreased circulating Klotho is associated with  decreased muscle strength (86).  
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The emerging evidence that mechanical stimuli promotes MuSC myogenicity, potentially 
through regulation of Wnt signaling activation and/or Klotho expression, provides support for the 
hypothesis that muscle contractile activity may be an effective and practical intervention strategy 
to reverse the effect of age on cellular and molecular mechanisms associated with an impaired 
regenerative response after injury.  
1.2.4 Electrical stimulation as a viable modality to promote MuSC myogenicity and 
counteract muscle regenerative deficits in aged animals 
Electrical Stimulation (Estim) is a modality that has been adopted in sports medicine and in 
rehabilitation settings as a complement and/or substitute to voluntary strength training (87). 
Studies have demonstrated that Estim may be used to recover contractile function, prevent atrophy 
associated with disuse of the skeletal muscle, and stimulate MuSC activation (88). Moreover, 
Estim effectively induces changes in the skeletal muscle microenvironment and, specifically, 
promotes skeletal muscle angiogenesis and the release of growth factors (89, 90). One study 
demonstrated that 5, 10, or 20 days of chronic low-frequency stimulation increased MuSC content 
in hypothyroidic muscles, suggesting that it may be an effective modality for enhancing activation, 
proliferation, and/or the fusion of MuSCs (91). Additionally, five days of Estim increases VEGF 
secretion and blood flow within the muscle in a rat model ischemia (77), further confirming the 
ability of Estim to be a potent modulator of the skeletal muscle microenvironment. 
Caggiano and colleagues compared the training effects of electrical stimulation and 
voluntary isometric contraction protocol (traditional exercise on the quadriceps strength) of 65 
year old males (92). They observed that Estim had the same capacity to increase torque as 
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traditional exercise in older males. At molecular level, Kern et al, demonstrated that 9 weeks of 
Estim administered to bilateral anterior quadriceps in old sedentary males increased the expression 
biomarkers of activated MuSCs and myoblasts, such as IGF-1, and promoted the remodeling of 
myofibers and extracellular matrix (ECM) (93). These results suggest that Estim attenuates the 
functional decline associated with aging, and improves muscle strength and mass.  Moreover, Guo 
et al. demonstrated that Estim provides an effective stimulus to prevent the loss of myonuclei and 
MuSCs in models of disuse muscle atrophy (88). Although several studies have demonstrated and 
elucidated skeletal muscle responses to Estim (94-97), the ability of Estim to modulate the aged 
skeletal muscle microenvironment and promote a rejuvenated MuSC phenotype is unknown. We 
hypothesize that targeted muscle contractile activity, elicited by Estim, reverses the age-related 
decline in skeletal muscle regenerative capacity at the tissue, cellular and molecular levels (Figure. 
3) 
 
 
           
Figure 3. Hypothesis schematic 
Figure 3. Decreased muscle function that typically follows the aging process (left).  We hypothesize that Estim 
reverses age-related declines in muscle stem (satellite) cell (MuSC) regenerative potential, and, ultimately, muscle 
function. 
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1.3 SIGNIFICANCE 
In an elderly population, muscle weakness and atrophy occurs soon after the onset of decreased 
mobility, and previous studies have shown that lower extremity strength is an important 
determinant of fall risk (98, 99). Targeted interventions to prevent such a devastating cycle have 
the potential to hasten an elderly individual’s return to previous level of functioning. We anticipate 
that completion of these studies will serve as an important first step in the development of therapies 
designed to counteract and/or reverse the effect of age on skeletal muscle regeneration after injury. 
An improved understanding of molecular and cellular mechanisms controlling tissue-healing 
response may reveal novel pharmacological targets to increase enhance skeletal muscle functional 
capacity in an aged population.   
We propose that muscle contractile activity is an effective tool for modulating skeletal 
muscle regenerative potential, and the expansion of these studies will be important steps towards 
the development of targeted treatment interventions to prevent muscle wasting and weakness 
following periods of prolonged immobility, such as after a severe muscle injury, following an 
intensive care unit stay, or post-operatively. In addition, we propose that Estim that may be a 
beneficial modality to rejuvenate the aged skeletal muscle environment prior to undergoing an 
elective surgical procedure that involves significant muscle trauma, such as a total hip arthroplasty 
or spinal surgery.  Such procedures result in considerable muscle damage, which may lead to 
decreased tissue blood flow, muscle atrophy, and decreased muscle strength (100); the resulting 
degenerative changes are oftentimes long-lasting (101). We propose that pre-operative treatment 
with Estim may better position aged skeletal muscle for an accelerated regenerative response post-
operatively, ultimately contributing to a faster return to functional mobility.   
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1.4 INNOVATION 
This study is innovative because it implements a clinically-relevant and cost-effective modality, 
Estim, as a means to target MuSC responses and promote enhanced regeneration of aged skeletal 
muscle. Although Estim has been investigated in many studies in the context of muscle 
hypertrophy and healing, further investigation is needed to analyze the underlying mechanisms by 
which Estim may modulate MuSC behavior in aged muscle. 
This research is also innovative because it integrates basic science principles with 
rehabilitation approaches, an integration that may aid in the development of targeted protocols 
designed to enhance muscle healing in a geriatric population. This project will allow us to 
discriminate the effects of mechanical loading at the molecular, cellular, histological and 
functional levels with the goal of better understanding how mechanical stimulation may attenuate, 
prevent or reverse muscle impairments in a geriatric population. 
1.5 AIMS AND HYPOTHESIS 
The overall objective of this work is to investigate the ability of Estim to reverse the effect of age 
on skeletal muscle healing process. To test our hypothesis that Estim may reverse age-related 
declines in myofiber regeneration after injury, Specific Aim 1 will examine histological evidence 
of muscle regeneration, and physiological strength recovery among Young Control (YC), Young 
Injury (YI), Aged Control (AC), Aged Injury (AI), and Aged Estim (AEI) groups.  
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  In Specific Aim 2, we will analyze the effect of Estim on in vitro muscle progenitor cell 
(MPC) characteristics, including myogenic differentiation and activation of the myogenic 
molecular program.  For in vitro characteristics, MPCs from all experimental groups, Young 
Control (YC), Aged Control (AC), and Aged Estim (AE), will be isolated in order to investigate 
the effect of Estim on cellular terminal differentiation and senescence. Moreover, we will employ 
a gain- and loss-of function paradigm to test our hypothesis that the beneficial effect of Estim on 
MPC myogenicity is a result of inhibition of the Wnt signaling cascade by Klotho. 
 
1.5.1 Specific aims and hypothesis of study 1 
To determine the ability of Estim to improve the regeneration and functional recovery of 
aged skeletal muscle after acute muscle injury.  
Hypothesis: Estim will improve myofiber regeneration (as evidenced by the number and 
size of regenerating fibers), and decrease fibrosis formation (as evidenced by a decreased collagen 
deposition) after injury in aged skeletal muscle. This enhanced tissue regeneration will be 
associated with a significantly enhanced functional recovery (as determined by in situ contractile 
testing).   
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1.5.2 Specific aim and hypothesis of study 2 
To determine the ability of Estim to rejuvenate the regenerative potential of MuSCs through 
a Klotho-mediated inhibition of Wnt signaling  
Hypothesis: Estim will increase the viability (as evidenced by an enhanced metabolism and 
senescence) and myogenic capacity (as evidenced by the expression of myogenic marker, desmin) 
of aged MPCs. These alterations will be associated with a down-regulation of Wnt signaling 
activation, as evidenced by a decreased expression of nuclear β-catenin and increased expression 
of GSK3. Finally, we hypothesize that Estim induces an increase in local Klotho expression, 
thereby inhibiting Wnt signaling activation in aged MPCs.  
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2.0  NEUROMUSCULAR ELECTRICAL STIMULATION REJUVENATES THE 
REGENERATIVE POTENTIAL OF AGED MUSCLE PROGENITOR CELLS  
2.1 SUMMARY 
Increasing age typically results in a decreased skeletal muscle regenerative capacity and increased 
fibrosis after injury, ultimately contributing to a weakness and declines in physical functioning. 
With age, stem cells display cell-autonomous alterations that predispose the muscle to an impaired 
regenerative potential. However, many of these age-related changes have been shown to be 
reversible through rejuvenation of aged stem cell responses.  Here, we test the hypothesis that 
mechanical stimulation via neuromuscular electrical stimulation (Estim) boosts the regenerative 
potential of aged muscle progenitor cells (MPCs) and improves skeletal muscle regeneration after 
injury. Estim is an attractive modality since it has been shown to enhance secretion of myogenic 
and angiogenic growth factors, as well as inhibit fibrogenic pathways. Our results demonstrate that 
two weeks of Estim enhances myofiber regeneration and increases tetanic force recovery in aged 
muscles after an acute injury. Improved muscle regeneration in aged muscle following the 
application of Estim is concomitant with a rejuvenated muscle progenitor cell (MPC) phenotype, 
as demonstrated by a decreased activation of the pro-fibrogenic pathway, Wnt signaling, as well as 
a decreased senescence. Finally, our results suggest that the beneficial effect of Estim on MPC 
regenerative potential is concomitant with an up-regulation of the anti-aging protein, Klotho. Taken 
together, these data provide evidence that Estim may be a great mechanical stimulus to improve 
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functional recovery after an acute injury in aged muscle and activate important pathways to 
modulate the anti-aging declines. 
2.2 INTRODUCTION 
Age-related skeletal muscle weakness and impairment in regenerative capacity following damage 
is a major contributor to declines in functional mobility and is associated with an increased 
morbidity in an elderly population (1). After injury, the skeletal muscle of aged individuals 
demonstrates increased skeletal muscle fibrosis formation and adipose tissue accumulation (8, 15, 
24). These are concomitant with an impaired myofiber regeneration and subsequent decrease in 
muscle contractility (103-106). A better understanding of the cellular mechanisms controlling age-
related skeletal muscle dysfunction will aid in the development of clinically relevant approaches 
to address this significant problem. 
The ability of skeletal muscle to repair itself after injury is largely dependent on the 
response of muscle stem (satellite) cells (MuSCs). After injury, MuSCs are activated to become 
myoblasts, which subsequently fuse to form myofibers (107). However, aging typically culminates 
in a multitude of compromised MuSC responses. Several decades ago, it was proposed that a 
dramatic decrease in the absolute number of MuSCs in aged skeletal muscle may underlie the 
observed age-related impairment of healing after injury (37). More recently, studies have 
demonstrated that autonomous defects within the resident MuSC population may primarily explain 
the deficit in muscle regeneration of aged muscle. Aged MuSCs display an impaired ability to 
respond to an injury stimulus, owing in large part to a reduced capacity for myogenic 
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differentiation (108). Specifically, aging disrupts MuSC lineage specification, as demonstrated by 
a myogenic-to-fibrogenic conversion (7, 39).  
The skeletal muscle microenvironment is an important regulator of MuSC function.  
Studies using heterochronic parabiosis, in which the circulatory systems of young and aged 
animals are surgically joined, have demonstrated that exposure of aged MuSCs to a young 
microenvironment restores myogenic capacity to youthful levels. This enhanced MuSC behavior 
is concomitant with an improved healing response after an acute injury (9, 39, 49).  Importantly, 
it has been shown that the improved muscle healing of aged parabiotic partners is not the result of 
a physical contribution of the young cells within the circulation (109), suggesting that systemic 
niche factors play a critical role in dictating MuSC behavior. In vitro models revealed that, when 
MuSCs were exposed to mouse serum derived from aged mice, young MuSCs display an increased 
fibrogenic conversion. This increased fibrogenic conversion was further associated with an 
increased Wnt signaling activation. Whereas canonical Wnt signaling is typically activated in 
young healthy muscle (43-45), aged MuSCs demonstrate an excessive activation of the Wnt 
signaling pathway, which has been shown to ultimately result in a dysfunctional myogenesis and 
increased fibrosis at the injury site (7). Intriguingly, when aged MuSCs are exposed to serum 
derived from young mice, the cells display a decreased Wnt signaling activation and an enhanced 
myogenic potential(7). These findings suggest that some circulating factor found in young serum 
may inhibit or functionally neutralize activation of the Wnt signaling cascade. 
Similar to the rejuvenating effects of heterochronic parabiosis, physical activity induces a 
myriad of anti-aging effects, including prevention of muscle wasting, cardiovascular diseases, 
hypertension and diabetes. There has been mounting evidence to suggest that muscle contractile 
activity, by exercise or electrical stimulation (Estim), may also enhance muscle progenitor cell 
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(MPC) regenerative potential (110, 111).  In both animals and humans, it has been shown that 
muscle loading induces the activation and proliferation of MPCs, promotes skeletal muscle 
angiogenesis, and stimulates the release of myogenically favorable growth factors (reviewed in 
(90, 112)). In the current study, we tested our hypothesis that skeletal muscle contractile activity 
mitigates the effect of age on MPC function and skeletal muscle healing capacity. Our results 
demonstrate that two weeks of Estim restores MPC myogenicity to youthful levels, and that this 
enhanced cellular functioning is consistent with a decreased Wnt signaling activation and 
decreased cellular senescence. We further present evidence to suggest that the beneficial effect of 
Estim on MPC senescence is mediated by an up-regulation of the circulating longevity protein, 
Klotho. Importantly, the rejuvenating effects of Estim on MPC behavior are concomitant with 
evidence of enhanced histological and functional recovery two weeks after injury.  
2.3 METHODS 
2.3.1 Skeletal muscle injury 
For the in vivo study, a total of forty animals (n=16, 14-16 weeks old mice; n=24, 22-24 months 
old mice) were divided into the following groups: Young control (YC), Aged Control (AC n=8), 
Young + Injury (YI), Aged + Injury (AI n=8), and Aged+Estim+Injury (AEI n=8). For the in vitro 
study, a total of fifty animals were divided in 3 groups: (YC n=15), (AI n=20), and (AE n=15). All 
experiments were performed with prior approval from the Institutional Animal Care and Use 
Committee of the University of Pittsburgh. Mice were anesthetized with 2% isofluorane, 
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administered by inhalation during muscle injury, functional contractile testing, and euthanasia. 
Cardiotoxin (CTX) was intramuscularly injected into bilateral tibialis anterior (TA) muscles in 
order to induce an acute muscle injury in all experimental groups after 5 sessions of Estim 
(performed over the course of 10 days).  Young Injury and Aged Injury animals that were not been 
treated with Estim were similarly injured bilaterally.  
For the injury, mice were anesthetized with 2% isoflurane (Abbott Laboratories, North 
Chicago, IL) in 100% O2 gas. The hair was shaved and the skin was cleaned with isopropyl 
alcohol. CTX from Naja mossambica mossambica venom (Sigma C9759) was prepared with 
phosphate-buffered saline (PBS) at a concentration of 1μg/μl. Ten microliters of CTX were 
injected into bilateral TAs. Since there was no significant difference in the muscle weights across 
age groups (Young mice: 58.5±1.3 mg; Aged mice: 58.8±1.5 mg), an equal volume of CTX was 
injected into all muscles.  
2.3.2 Electrical stimulation (Estim) protocol 
Neuromuscular electrical stimulation was performed using a Neuromuscular Stimulator (Empi 300 
PV, St Paul, USA) and modified surface electrodes, as we previously described (113). Prior to 
stimulation, the anterior lower limb was shaved and cleaned with alcohol. Location of the peroneal 
nerve was confirmed when stimulation resulted in a full hindlimb dorsiflexion and digit extension, 
indicating stimulation of the anterior compartment muscles, including the TA and extensor 
digitorum longus (EDL) muscles. Estim was performed bilaterally for two sets of ten contractions 
per session, for a total of five sessions and at least one day of rest between each session. The 
intensity was started at 9mA and was increased by 1.0mA when the animal was able to complete 
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two full sets (typically 2 days). We have found that this progression of stimulation does not 
contribute to additional muscle injury and does not result in any visible gait impairment as observed 
in our previously study using the same Estim protocol as described by Distefano (2013) (111). The 
parameters used include: pulse duration of 150ms, frequency of 50Hz, time on: 5 seconds, time off: 
10 seconds, 0.5-second ramp and 0.5-second ramp down. This protocol was based on clinical 
protocols designed to increase muscle strength according to the principle of increased functional 
load (114, 115). 
2.3.3 In situ contractile testing 
Contractile testing was performed 14 days after injury using an in situ testing apparatus (Model 
809B, Aurora Scientific Inc, Canada), a stimulator (Model 701C, Aurora Scientific Inc, Canada), 
and a force transducer (Aurora Scientific Inc, Canada). The method used allows for the 
determination of muscle contractile properties of a muscle of interest, while maintaining normal 
muscle orientation, innervation and vascular supply (111). Briefly, the peroneal nerve of 
anesthetized animals was isolated through a small incision lateral to the left knee. Mice were then 
placed supine on a 37oC-heated platform and the foot being tested is positioned on the footplate. 
The left hindlimb used for testing was stabilized with cloth tape on the knee and foot. Muscles 
were stimulated through the peroneal nerve by a hook electrode inserted beneath the skin. Muscle 
peak twitch, time to peak twitch and half-relaxation time with the ankle positioned at 20o of 
plantarflexion, the position that we determined to result in the greatest force output (data not 
shown), were quantified. Tetanic contractions at 10, 30, 50, 80, 100, 120, 150 Hz were elicited to 
obtain a force- frequency curve, with a 2-minute rest between each contraction. The muscles were 
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then subjected to a 7 minute high-frequency fatigue protocol consisting of a series of short 350ms 
tetanic contractions at 100 Hz, with 4-second intervals between contractions (116). Force recovery 
was analyzed at 5 and 10 minutes following completion of the fatiguing protocol, as we previously 
described (111, 117). Right TA muscles from mice in each group were then harvested and frozen 
in nitrogen-cooled 2-methylbutane for subsequent histological analysis by blinded investigator. 
2.3.4 Histology and immunofluorescence 
Frozen muscles were serially sectioned (10 μm sections) at -30oC on a Thermo Scientific cryostat 
and mounted onto slides. Histological assessment of the recovery process was performed in groups 
of control and injured mice 14 days after injury.  
Laminin Immunofluorescence: Slides were washed 3x with 1x PBS and permeabilized with 
0.03% Triton X-100 in PBS for 20 min at room temperature. Slides were then blocked with 5% 
Normal Goat Serum (Vector S-1000) in PBS for 60 min at room temperature. Slides were washed 
3x with 1x PBS and 3x with 0.5% Bovine Serum Albumin (BSA). Slides were then incubated with 
Rat anti-Laminin primary (1:100, Abcam 11576) for 60 min at room temperature. Slides were 
washed 3x with 0.5% BSA and incubated with Goat anti-Rat Alexa Fluor 488 secondary (1:500, 
Life Technologies A-11006) for 60 min at room temperature. Slides were washed 3x with 0.5% 
BSA, 3x with 1x PBS, and incubated with 4’,6-diamidino-2-phenylindole (DAPI) (Life 
Technologies 1370421) for 1 min at room temperature. Slides were washed 6x with 1x PBS and 
cover slips were mounted with Cytoseal XYL (Richard-Allen Scientific 8312-4). Slides were 
imaged (20x magnification) using a Nikon 90i motorized upright fluorescent microscopy. 
Myofiber diameter and the total number fibers were determined utilizing an automated macro 
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written in Nikon Elements AR (Nikon Elements AR, Nikon, Tokyo, Japan). To calculate the 
myofiber diameter we calculated how many individual bundles of fibers there were. After, the 
average area of everything divided by the total number of fibers gave us the average area per fiber. 
Fibrogenesis: Masson’s Trichrome staining was performed to quantify the percent of 
collagen content and muscle fiber in a muscle section. Slides were processed using Masson’s 
Trichrome Stain Kit as per manufacturer’s instructions (K7228; IMEB, Chicago, IL). This process 
stains skeletal muscle fibers red, collagen blue, and nuclei black. For each sample, three random 
sections were selected and photographed using Nikon 90i motorized upright fluorescent 
microscopy and NIS-Elements. The percentage of the total collagen-positive area relative to the 
total cross-sectional area was calculated. For determination of collagen content, sections were 
analyzed using MetaMorph Offline. 
 
2.3.5 MPC isolation 
TA and Extensor Digitorum Longus muscles from bilateral hindlimb muscles of 5 animals per 
experimental group (young, aged, and aged+Estim) were harvested for MPC isolation using a 
modified pre-plate technique, as previously described (26, 118, 119). Briefly, after hindlimb muscle 
enzymatic digestion, the homogenate was serially plated onto collagen-coated flasks. It has been 
previously shown that cells that rapidly adhere to the collagen-coated flasks (passage 1 and 2) are 
predominantly of a fibroblastic lineage (26). On the other hand, those late adhering cells, isolated 
after three or four serial passages, have been previously characterized as having a myogenic lineage 
(26). All cells were expanded in high-serum proliferation medium (Dulbecco’s modified Eagle’s 
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medium, 10% fetal bovine serum, 10% horse serum, 1% penicillin/streptomycin, and 0.5% chick 
embryo extract). Analyses were performed on MPCs that had been passaged fewer than three times 
in order to minimize the effect of chronic culture on MPC characteristics. Whenever possible, MPC 
analyses were performed by an investigator blinded to groupings.  
2.3.6 Metabolic activity (MTS) assay 
MPC viability was measured using CellTiter 96 Aqueous One solution (MTS: 3-(4,5-di- 
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-tetrazolium); Promega, 
Sunnyvale, CA) according to manufacturer’s instructions. In brief, 1,000 cells were seeded in each 
well of a 96-well plate and allowed to attach for 24 hours. Twenty μL of MTS solution was then 
added to the cells at 0, 1, 2, 3, or 7 days, incubated at 37 0C for 1 hour and quantified using a 
spectrophotometer (Tecan, San Jose, CA) at 490 nm. This assay is based on the conversion of a 
color reagent by NADPH or NADH, which is produced in metabolically active cells and is, 
therefore, indicative of the number of cells that are metabolically active. 
 
2.3.7 Senescence associated SA--Galactosidase (SA--Gal) activity assay 
This assay followed the method described by Debacq-Chainiaux et al.,(120) which is based on a 
histochemical stain for β-galactosidase activity (pH 6.0). In this assay, senescent cells are stained 
blue/green. Cells were washed with PBS and subsequently fixed in 2% PFA+0.2% glutaraldehyde 
in PBS for 5 min at room temperature, washed twice with PBS twice, and then incubated with a 
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staining mixture containing 5-bromo-4-chloro-3-indolyl β-d-galactoside, potassium ferricyanide, 
potassium ferrocyanide in citric acid–sodium phosphate buffer (pH 6.0) at 37 ̊C overnight. Cells 
were then washed with PBS and mounted with DAPI-fluoromount-G mounting media. Cells 
expressing SA--Gal were manually counted, and expressed as a percentage of the total cell count.  
 
2.3.8 MPC myogenicity 
To determine whether Estim can reverse the effect of age on MPC terminal differentiation, we 
compared in vitro myogenicity across groups. Cells from each population were seeded onto a 12-
well collagen-coated plate, and expanded to confluence in proliferation media (typically 3-4 days). 
Once cells were 70% confluent, the media was changed to a low-serum media in order to promote 
differentiation. After 3-5 days, immunofluorescence was performed on fixed cells (4% PFA, 10 
min) after permeabilization (0.2% PBT; 10 min) and blocking (5% GS in PBT). MPCs were then 
incubated in a primary antibody against desmin (myogenic marker). Cells were incubated in 
primary the primary antibody against desmin (1:1000) (overnight at 4°C at the following dilutions. 
Next, cells were washed and blocked in 5% GS/PBS then incubated in fluorophore-conjugated 
antibody (goat anti-rabbit Alexafluor 488 at 1/1000) and DAPI to visualize nuclei for one hour at 
room temperature. The percentage of cells positively stained cells for desmin was calculated as a 
function of total cell number (as determined by quantification of the total nuclear count).   
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2.3.9 Wnt signaling activation 
Flow cytometry was used to quantify the effect of Estim on Wnt signaling in MuSCs. MPC 
populations isolated from young and old animals were labeled with a fluorescent antibody specific 
to a substrate of Wnt signaling, -catenin. Cells were fixed with 4%PFA for 10 minutes at 370C 
and then permeabilized in 100% methanol for 30 minutes in ice and after that cells were kept in -
200C overnight. On the next day, 5ml of PBS was added and cells were centrifuged at 10000 rpm 
for five min. Cells were resuspended in 100 ml of PBS and 5 μl of first anti-body anti-human -
Catenin Alex Fluor 488 (ref#53-2567) was added and incubated at room temperature for one hour. 
Afterwards, cells were centrifuged, rinsed, and resuspended in 100 μl of PBS. Cells were 
subsequently incubated in 5μl of second anti-body mouse IgG1 K Isotype Control Alex Fluor 488 
(ref#53-4714) for 30 minutes at room temperature. Finally, cells were rinsed with PBS, 
centrifuged, and resuspended in 0.5ml of phosphate buffered saline (PBS). Cells were analyzed 
using fluorescence activated cell sorting (FACS) and gated to include cells with fluorescence for 
MuSCs markers, CD31-, Sca1-, CD45- and VCAM+ (Fig 4). β-Catenin expression was evaluated 
in a MuSC sub-population and the percentage of positively stained cells for each variable was 
compared across groups.  
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Figure 4 - Gating strategy for sorting of MuSCs from the MPC population 
In this sample gating strategy, cells were isolated from TAs and EDLs and analyzed by flow 
cytometry. (A-D): Gating strategy for analysis of 106+ population. (A) Gating for cells based on 
forward and side scatter. (B-C) Cells were first gated for singlets versus doublet populations, and 
then cells were gated for CD31- and 45-, and Sca1-. (D) Only triple negative cells were gated for 
106+. Abbreviations: FSC-A, Forward Scatter Area; SSC-A, Side Scatter Area; FSC-H, Forward 
Scatter Height; FSC-W, Forward Scatter Width.  
 
For GSK-3β analysis, MPCs were plated in 12 well-coated plates and after 24 hours they 
were incubated with primary antibody (anti-GSK3 beta antibody (ab2602) at 1:100 overnight at 
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40C). Cells were incubated with second antibody (488 goat anti rabbit, respectively) at 1:100 for 1 
hour following the manufacturer’s recommendation. The average intensity of fluorescence was 
quantified across group. 
2.3.10 Immunocytochemistry protocol to evaluate Wnt and Klotho 
Samples were incubated with primary antibodies rat anti-Klotho (R&D, MAB1819) and mouse 
anti β-catenin ( Thermofisher scientific, MA1-2001) overnight in 4C at 1:1000 dilution in 3% Goat 
serum (Jackson Laboratories, Product no. 005-000-121). After a triple wash with PBS, the cells 
were incubated with their respective secondary antibodies, goat-anti Rat Alexa Fluor 488 (Life 
Technologies, A11006), goat anti-mouse Alexa Fluor 594 (Life Technologies, A11005) and 
Phalloidin 647 in 3% Goat serum at 1:500 dilution for 60 minutes. The chamber slides were 
mounted with DAPI Fluoromount-G media (SouthernBiotech, 0100-20) with a glass 
coverslip after washing with PBS three times. Imaging was performed using a Nikon Confocal All 
images were obtained at the same exposure for each channel. ImageJ was used to analyze confocal 
images for intensity of Klotho and -catenin in the region of interest. 
 
2.3.11 siRNA Klotho knockdown 
MPCs were plated to 70% confluence, after which time they were transfected with 50nM of pools 
of siRNA specific for Klotho or with 25nM of both specific siRNA pools (siGENOME SMART 
pool, Dharmacon, Lafayette, CO) using Dharmafect 1 reagent (Dharmacon) according to the 
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supplier's protocol. As a negative control, cells were transfected with 50nM of Non-Specific Pool 
#2 siRNA (siGENOME SMART pool, Dharmacon. Four days post transfection, the cells were 
placed in differentiation media for 2 days, and nuclear β-Catenin expression and senescence were 
subsequently evaluated, as described above.  
2.3.12 Statistical analysis 
Analyses were performed using SPSS v22.0 software (Armonk, NY). Shapiro-Wilk and Levene’s 
tests were initially performed to assess normality of data and equality of variances, respectively. 
If assumptions of normality and homogeneity of variances were met, a one-way ANOVA followed 
by post-hoc Tukey tests were performed to compare differences across groups. However, because 
normality conditions were not met and the distribution was not normal, Post hoc comparisons 
between groups were performed using the non-parametric Kruskal-Wallis test followed by Mann-
Whitney U tests. Multiple linear regressions were performed for the in situ contractile data, to 
investigate the slopes of muscular fatigue and recovery in different time points. Non-linear 
regression using exponential growth modeling on normalized data was performed for the 
proliferation assay results to evaluate the cells metabolic activity in different time points. All 
results were expressed as mean ± standard error. Statistical significance was established, a priori, 
at p≤0.05.  
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2.4 RESULTS 
2.4.1 Estim enhances myofiber regeneration and force recovery in aged skeletal muscle 
after an acute injury 
As expected, acutely injured aged muscle displayed a significant impairment in myofiber 
regeneration, as determined by a decrease in total number of myofibers (TNF) and the myofiber 
cross-sectional area (CSA), when compared to young injured counterparts (p=0.009 and p<0.001; 
respectively) (Figure 5). However, two weeks of Estim significantly increased regeneration in 
acutely injured aged muscle, when compared to age-matched controls (TNF: p=0.009, CSA: 
p<0.001) (Figure 5).  There was no difference in the regeneration of aged muscle that had been 
exposed to Estim and young counterparts (TNF: p=0.465, CSA: p=0.785) (Figure 5).  
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Figure 5. Effect of pre-treatment Estim on the total number fiber and cross sectional area in aged 
mice. 
(A) Total number fibers in all experimental groups 14 days after cardiotoxin injury (n=7-8/group). 
(B) Cross sectional area of TA muscles in across the experimental groups: Young control (YC); 
Aged control (AC); Young injured (YI); Aged injured (AI); and Aged injured + Estim (AEI). (C) 
Laminin staining in the tissue cross-sections of TA muscles in all groups (Green=Laminin, Blue= 
DAPI).  n=7-8/group, (20x magnification, scale bar=100μm).**Denotes significantly different 
p=0.0019, ***Denotes significantly different p<0.0005, ****Denotes significantly different 
p<0.0001.  
 
Analysis of collagen content revealed no significant difference in fibrosis formation 
between any of the injury groups evaluated (Figure 6).  
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Figure 6 Effect of pre-treatment Estim on the percentage of scar tissue formation in aged mice 
(A) Percent of collagenous tissue across experimental groups. (B) Masson’s Trichrome stain 
(Fibers (Red); Collagen (Blue), and Nuclei (Black)) in the tissue cross-sections of TA muscles of 
Young Control (YC), Aged Control (AC), Young Injury (YI), Aged Injury (AI), and Aged Estim 
Injury (AEI) 14 days after cardiotoxin injury (CTX) (10x magnification, scale bar = 100 μm). 
*Denotes significantly different p<0.05; **Denotes significantly different p<0.01. 
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To examine whether the enhanced regenerative response following the application of Estim in 
aged animals was concomitant with an improved force recovery after injury, we performed in situ 
contractile muscle testing. Fourteen days post injury, the specific tetanic force tested at 100Hz in 
aged injury muscle was significantly lower when compared young injury counterparts (p=0.006) 
(Figure 7A). However, completion of an Estim protocol restored force recovery in aged muscles 
to levels comparable to young counterparts (p=0.509; Figure 7A; Table 1), and significantly 
greater than age-matched injured muscles (p=0.046; Figure 7A and C; Table 1). There was no 
difference in the fatigue resistance or recovery from a fatiguing protocol at 5 or 10 minutes 
recovery between injured groups (Figure 7 B), but all injured muscles displayed a decreased 
recovery from a fatiguing protocol when compared to uninjured controls at 5 and 10 minutes 
recovery (p≤0.001). Analysis of temporal contractile characteristics revealed no differences in time 
to peak twitch or half relaxation time between groups (Table 1).  
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Figure 7 In situ contractile testing of the lower leg anterior compartment 
Fourteen days after cardiotoxin injury, in situ contractile testing of tetanic force production in the anterior leg muscle compartment was 
performed in Young Control (YC), Young Injury (YI), Aged Control (AC), Aged Injury (AI), and Aged Estim Injury (AEI). (A) Force 
Frequency Curve; (B) Quantification of fatigue resistance and force recovery after a fatiguing protocol; (C) Peak tetanic force at 100Hz. 
Data are mean ± standard error of the mean (SEM) for all experimental groups. * p<0.05 when comparing to AEI.
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Table 1.  Contractile characteristics 
                  
Data are presented as the mean ± SEM and statistical differences were determined by one-way ANOVA (p<0.05). #Significantly 
different when compared to YC and AC; **Significantly different when compared to AI.
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2.4.2 Estim rejuvenates the aged MPCs phenotype 
We next tested whether the enhanced regenerative response following Estim was associated with 
an altered MPC phenotype. Flow cytometry analysis revealed that ~68% of the young and 50% of 
aged populations were CD106+, Sca1-,CD31, and CD45-, an expression profile show to be highly 
selective for MuSCs (118, 119). Interestingly, aged animals that completed an Estim protocol 
displayed a MuSC profile that closely paralleled that of young counterparts, and approximately 
65% of cells isolated from were CD106+, Sca1-, CD31, and CD45- (Figure 8).  
 
Figure 8 FACS sorting for 106+ cells to isolate pure MPCs population 
Cells were isolated from TA and EDLs muscle of Young Control (YC), Aged Control (AC), and 
Aged Estim (AE). Cells were stained for CD31-, CD45-, Sca1-, and CD106+ (indicative of an 
MuSC subpopulation), and analyzed by FACS. Fluorescent staining of sorted cells from all 
experimental groups shows the percentage (y-axis) and intensity (x-axis) of MuSCs. 
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Consistent with previous studies (121), MPCs isolated from aged animals demonstrated a 
significantly decreased myogenesis, when compared to young controls (Figure 9). However, 
following Estim, aged MPCs displayed a myogenic differentiation comparable to young 
counterparts, * p=0.03 (Figure 9 A and B).  
 
Figure 9 Effect of Estim on MPC myogenicity  
(A) MPCs were fixed and immunostained for Desmin, a myogenic marker (Green) and the nuclear 
stain, DAPI (Blue) in Young Control (YC), Aged Control (AC), and Aged Estim (AE). *, p=0.03. 
(B) Graph showing the percentage of cells positive for Desmin. Scale bar=100 μm 
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 When we examined MPC viability across experimental groups using an MTS assay, we 
observed a significant decrease in the metabolic activity of aged MPCs relative to young 
counterparts (p<0.0001), but the metabolic activity of aged MPCs was restored to youthful levels 
following completion of an Estim protocol (p<0.001) (Figure 10). 
                                        
 
Figure 10. Metabolic viability assay of MPCs 
 Line graph showing an increased in cell viability assay in Young Control (YC) and Aged Estim 
(AE), when compared to Aged Control (AC). 
 
When we analyzed cellular senescence across the three groups, we observed a significant 
increased in senescence-associated beta-galactosidase (SA--gal) staining of MPCs isolated from 
the skeletal muscle of aged mice, relative to young controls (Figure 11A, B). These results are 
consistent with previous findings reporting an increased cellular senescence of aged MuSCs, as 
determined by p16Ink4a and p21Cip1(123). Following completion of Estim protocol in aged animals, 
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however, the percentage of senescent MPCs resembled levels comparable to young counterparts, 
demonstrating an improved capacity of Estim to rejuvenate aged MPC (124, 125) (Figure 11A, B). 
 
 
Figure 11 Estim decreases the percentage of senescent cells in aged MPCs 
(A) SA--gal staining (blue) of MPCs isolated from the skeletal muscle of Young Control (YC), 
Aged Control (AC) and Aged Estim (AE) mice. Scale bar=50μm. (B) Graphic representation of 
the percentage of senescence cells across each of the three experimental groups. The number of 
SA--gal positive cells is significantly increased in AC cells, when compared to YC. However, 
the percentage of senescent cells is significantly decreased in AE, when compared to AC group. 
** p≤0.005.  
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2.4.3 Estim modulates Wnt signaling/β-Catenin pathway in aged MPCs 
Given previous reports demonstrating a role for Wnt signaling in age-related declines in MuSC 
function, we next tested whether Estim may affect MPC myogenicity through modulation of Wnt 
signaling activation. Though flow cytometry analysis revealed that the aged MuSC subpopulation 
display an increase in Wnt signaling activation relative to young counterparts (Figure 12 A), 
consistent with previous reports (7, 58), the application of an Estim protocol decreased the 
percentage of nuclear -catenin positive cells when compared to aged controls (Figure 12A). These 
findings were further confirmed by immunocytochemical analysis of nuclear -catenin (Figure 
12D and E).  Finally, analysis of glycogen synthase kinase 3 (GSK3), important for maintenance 
of the -catenin degradation complex and, therefore, inhibition of -Catenin nuclear translocation, 
revealed that Estim mitigated the age-related decrease in the percentage of GSK3 expression to 
values comparable to young controls (p=0.002) (Figure 12 B and C). Taken together, these findings 
suggest that the application of an Estim to aged skeletal muscle decreases Wnt signaling activation 
in aged MPCs.
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Figure 12 Estim modulates Wnt/β-Catenin pathway 
(A) Flow cytometry analysis of the intensity of β-Catenin present in the MuSC population of Young Control (YC), Aged Control (AC), 
and Aged Estim (AE). (B) Immunocytochemestry for GSK3 in MPCs from across the three groups (Green). Scale bar =100 μm. (C) 
Percentage of GSK3 is decreased in Aged Control MPCs, when compared to Young controls (YC). However, Aged Estim (AE) display 
a significant increase in GSK3 when compared to Aged Control (AC). * denotes p<0.005 (D) Cells were fixed and stained for β-Catenin 
(Red) and DAPI for nuclei (Blue). Scale bar = 50μm (E) Quantification demosntrates significantly increased levels of nuclear β-Catenin 
in AC MPCs when compared to YC and AE, **** p<0.0001.
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2.4.4 MPCs display an aged-related decrease in Klotho expression, but Estim restores 
expression to youthful levels 
Heterochronic parabiosis experiments suggest that the introduction of youthful factors into the 
circulation of aged partners is sufficient to inhibit MuSC Wnt signaling activation and restore 
myogenic potential (47). However, the primary protein responsible for eliciting such rejuvenating 
effects is still unclear. One potential candidate of interest is the circulating hormone, Klotho. In 
tissues such as the skin and small intestine, declines in Klotho have been associated with inhibition 
of Wnt signaling activation and stem cell dysfunction (126). We therefore wondered if the 
beneficial effect of Estim on MPC function and regenerative potential in aged muscle might be a 
result of an up-regulation of Klotho expression. 
To test this hypothesis, Klotho expression in injured young, aged and aged skeletal muscle 
exposed to Estim was quantified using immunofluorescence. Klotho expression was highly 
expressed at the site of acutely injured young skeletal muscle, but expression was markedly 
attenuated in the injured muscle of aged muscle (Figure 13). Strikingly, Klotho expression at the 
injury site of aged muscle was restored to youthful levels following completion of an Estim 
protocol (Figure 13). 
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Figure 13 Klotho expression after skeletal muscle injury 
(A) Tibialis Anterior (TA) muscles were stained for Klotho expression (Green), myofibers 
(phalloidin; Red), and DAPI  for nuclei (Blue). (B) Immunocytochemistry shows abundant Klotho 
expression after 14 days of CTX in Young Control (YC), but expression is significantly decreased 
in Aged muscle (AI). However, Aged Estim (AE) muscles displayed a Klotho expression 
significantly greater than age-matched controls, and to levels comparable to young counterparts. 
Scale bar 50 μm. ****p<0.0001. 
 
We next evaluated Klotho expression in MPC isolates from the three groups using confocal 
microscopy. Consistent with histological findings, young MPCs highly expressed Klotho 
throughout the nucleus and cytoplasm. Although Klotho expression was markedly decreased in 
aged MPC counterparts, when MPCs were isolated from aged muscle following completion of an 
Estim protocol, Klotho expression resembled that of young counterparts (Figure 14).  
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 Figure 14  Estim restores the expression of longevity protein, Klotho, in aged MPCs 
(A) Immunocytochimistry for Klotho expression (Green) and nuclear stain (DAPI; blue).  Scale bar = 50 μm. (B) Aged Control (AC) 
MPCs display significantly decreased expression of Klotho as compared to Young Control (YC) MPCs, *** denotes p<0.001. 
However, Estim increases Klotho expression in Aged Estim (AE) MPCs, as compared to Aged Control (AC). ** denotes p<0.01. 
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To further interrogate a potential role for Klotho in modulating MPC function, Klotho 
expression was inhibited using siRNA to Klotho in YC MPCs and AE MPCs; an inhibition which 
resulted in MPC Klotho levels comparable to that observed in aged MPCs (Figure 15A). 
Unexpectedly, we found that inhibition of Klotho in young MPCs and aged MPCs MPCs did not 
significantly increase nuclear β-catenin levels, as compared to YC or AE MPCs treated with a 
scramble control (Figure 15 B).  
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 Figure 15 Silencing Klotho in Young Control and Aged Estim MPCs increases levels of β-catenin 
Cells from Young control (YC) and Aged Estim (AE) were cultured and treated with siRNA to Klotho. Counterparts were treated with 
a non-coding (scramble) vector. Cells were fixed and immunostained for β-catenin and Klotho. (A) Klotho intensity decreases with 
silencing Klotho in the same levels of Aged Control, **** p<0.0001 (B) β-catenin increases in both Aged Control and Young+siRNA, 
****p<0.0001, ***p=0.0003, **p=0.005.  
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Since we did not observe the expected increase in nuclear β-catenin when Klotho was 
inhibited in our MPC populations, we next evaluated the effect of Klotho expression on cellular 
senescence across groups using a loss-of-function paradigm. There was no significant difference 
between the percentage of senescent cells in YC and AE groups (p>0.05), therefore, the data was 
pooled across these two populations. Our data showed that inhibition of Klotho significantly 
increases the percentage of senescent MPCs in a dose-dependent manner, when compared to 
control counterparts treated with a non-coding vector (Figure 16). 
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Figure 16 Silencing Klotho affects the percentage of senescence cells in a dose-dependent manner 
(A) Representative images showing SA--gal staining (Blue) of MPCs with silencing Klotho at 
varying doses (0, 10nmol, 25nmol, and 50nmol). Scale bar=200 μm. (B) Bar graph showing 
quantification of the percentage of senescent MPCs across the different siRNA doses.
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2.5 DISCUSSION 
With advancing aging, the regenerative process of most tissues declines, and these declines are, in 
large part, attributed to dysfunction of tissue progenitor cells (9, 127). To better understand these 
declines with aging, it is necessary to identify the cellular and molecular mechanisms contributing 
to this impaired tissue function with age. Recently, studies have demonstrated the critical role of 
extrinsic factors within the niche for dictating MuSC regenerative potential (9, 128). In the present 
study, we investigated the influence of Estim on skeletal muscle regeneration in aged animals. 
Following two weeks of Estim, aged muscles displayed a myofiber regeneration and functional 
strength recovery comparable to young counterparts. Histological and functional improvements 
were concomitant with improvements in MPC characteristics, as evidenced by decreased in Wnt/β-
Catenin signaling activation. Moreover, two weeks of Estim was sufficient to restore the 
percentage of senescent MPCs to youthful levels. Finally, we provide evidence to suggest that the 
beneficial effect of Estim on MPC regenerative potential may be a result of increased Klotho 
expression within aged skeletal muscle.  
Many studies have demonstrated that mechanical loading, via exercise or Estim, for 
example, increases progenitor cell proliferative capacity and myogenicity (68, 81, 82, 93, 129-
131). One study using microcurrent electrical neuromuscular stimulation (MENS) demonstrated 
enhanced regeneration and an increased number of MuSCs following cardiotoxin injury in 7 week-
old mice (131). Another study compared leg press to Estim in 70 year-old subjects, and 
demonstrated that the application of Estim significantly increased the diameter of fast muscle 
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fibers and the number of Pax7 (a canonical MuSC marker) positive cells (132). Fujimaki and 
colleagues investigated the effect of functional overloading (FO) (via resistance exercise) on the 
plantaris muscle of 12 weeks old rats. Following FO, they found an increase in MuSC proliferation 
and differentiation, further confirming the ability of loading to modulate MuSCs responses (82).  
Consistent with these previous studies, we observed a significantly increased myogenicity 
of aged MPCs following completion of an Estim protocol. Moreover, this increased myogenicity 
was accompanied by a decreased activation of the Wnt signaling cascade, as evidenced by a 
decreased β-Catenin and an increased GSK3. Wnt/β-Catenin signaling is upregulated during 
normal myogenesis (45, 133). However, in aged mice, the molecular signatures underlying the 
skeletal muscle regenerative cascade are dramatically altered, and aged muscle displays excess 
activation of the Wnt/β-catenin signaling cascade, resulting in fibrosis formation at the expense of 
myogenesis (7, 9). In contrast to our findings, Fujimaki et al. (2014) demonstrated a decreased 
GSK-3 expression and increased Wnt signaling activation in skeletal muscle of adult and old mice 
after 4 weeks of voluntary wheel running (84). There are some key differences in the previous 
studies and the current study that may help explain the conflicting results. First, Fujimaki et al used 
implemented a 4-week voluntary wheel running protocol. It is possible that longer duration 
protocol eventually promotes up-regulation of Wnt signaling, perhaps through the onset of 
myofiber microinjury. In the case of the Estim training protocol used in the current study, we chose 
a low intensity protocol, which we previously demonstrated does not result in injury, but does 
modulate the microenvironment through an increased angiogenesis (111). In addition, the 
molecular responses to voluntary wheel running versus Estim are likely to be different, as wheel 
running represents a whole body exercise protocol, whereas Estim is highly localized to the muscle 
of interest. 
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Our study demonstrated that the enhanced regenerative response in aged muscle following 
two weeks of Estim was associated with an increased expression of the longevity protein, Klotho. 
Using the skin and small intestine as models, Liu and colleagues demonstrated that Klotho 
enhances stem cell regenerative potential and promotes tissue healing through an inhibition of Wnt 
signaling activation (58). These latter findings were confirmed in recent studies demonstrating that 
Klotho is able to directly bind to Wnt ligands extracellularly, thereby inhibiting renal fibrosis 
formation (134). In the light of these previous findings, we originally hypothesized the decreased 
Wnt signaling following Estim in aged muscle might be a result of increased Klotho expression. 
However, though we observed an increase in Klotho expression in the aged animals exposed to 
Estim, loss-of-function studies for Klotho did not drive the expected increase in β-catenin nuclear 
translocation. These findings suggest that other signaling pathways, independent of MPC Klotho 
expression, may mediate the observed decrease in Wnt signaling activation of aged MPCs 
following an Estim protocol.  
In contrast, we did observe a direct relationship between Klotho expression and the 
percentage of senescent MPCs. When Klotho was inhibited through siRNA in young MPCs and 
aged MPCs exposed to an Estim protocol, we observed a significantly increased percentage of 
senescence cells. These findings suggest that Klotho is inversely associated with senescence cells, 
and that Estim modulates Klotho expression in aged MPCs. Indeed, there is precedence to suggest 
that Klotho plays a role in inhibiting cellular senescence. Ikushima and colleagues demonstrated 
that Klotho has anti-senescent and anti-apoptotic roles in Human Umbilical Vein Endothelial Cells 
(HUVEC) through suppression of the p53/p21-signaling pathway (135), an important intracellular 
signal pathway of senescence. A follow up study by Maekawa et al. demonstrated that Klotho 
attenuates cellular senescence and apoptosis in HUVEC through inhibition of p53/p21 via the 
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Extracellular signal-Regulated Kinase MEK/ERK pathway, a subfamily of Mitogen-Activated 
Protein Kinase (MAPK)(136). 
A number of studies have demonstrated that, with exercise, muscles promote the secretion 
of a number of cytokines (137-139). Studies suggest that cytokines and other peptides that are 
expressed and released by muscle fibers, aka “myokines”, which have the capacity to promote 
paracrine and/or endocrine effects (140, 141). Indeed, several myokines, such as interleukin (IL)-
6 (142), AMP-activated protein Kinase (AMPK) signaling, etc. have been shown to be stimulated 
by exercise (143). Importantly, many of these exercise-induced myokines have been shown to 
affect MuSCs proliferation, regulation of fat oxidation, and induced protection against several 
chronic disease (138, 140, 141).  
Like heterochronic parabiosis and Klotho, physical activity induces a myriad of anti-aging 
effects, including prevention of muscle wasting, cardiovascular diseases and diabetes. 
Unfortunately, also like Klotho, physical activity levels have been shown to decline in both aged 
mice and men, which can limit the effectiveness of exercise and the benefits from it. Our findings 
suggest that Estim is a potent modality to modulate age-related declines in MPCs function and 
aged skeletal muscle regenerative capacity, possibly through regulation of Klotho expression. An 
important unresolved question is how does Estim regulate Klotho expression, and whether the 
Klotho expressed in acutely injured muscle originates from the circulation or the muscle itself? 
This would be an important line of future research.   
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2.5.1 Limitations 
To our knowledge, this is the first study to investigate the effect of Estim in aged skeletal muscle 
healing and the association of Wnt signaling, cellular senescence and Klotho expression in MPCs. 
While our results suggest that Estim is a promising intervention to promote muscle healing in aged 
animals, several limitations should be noted. First, cells used for analysis were expanded in culture 
prior to in vitro analyses.  Because only muscles directly exposed to Estim (ie. muscles of the 
anterior compartment) were used for cell isolation, the available muscle samples used for cell 
isolation were relatively small. As such, cells were necessarily expanded in vitro in order to obtain 
sufficient cell numbers for the analyses. Although all analyses were performed using cells that had 
undergone less than three passages, it cannot be discounted that amplification of cells in culture 
alters cellular characteristics and yields a heterogenous population (a phenomenon known as 
proliferation artifact). Therefore, isolated MPCs may not represent the behavior of cells in their 
native environment. Nevertheless, the fact that we demonstrate a significant improvement in force 
recovery after injury in aged mice following Estim, consistent with cellular and tissue findings, 
supports our hypothesis that Estim rejuvenates the regenerative response of aged muscle.   
Another limitation of this study is that we investigated only a single Estim protocol. 
Though we observed a significant improvement in the regenerative capacity of aged muscle using 
a low intensity, five-day protocol, it would be very informative for future studies to investigate 
how timing, duration and frequency of Estim may optimize outcomes. This could serve as 
important insight to ultimately guide the development of clinical rehabilitation protocols. Along 
these lines, the current study only compared two age groups, young versus aged. However, under 
ideal conditions, this study would compare multiple age groups so as to have better idea of the 
  
61 
trajectory of declines in regenerative potential over time, and how this may be modulated, or even 
prevented, by the application of mechanical stimulation protocols.  
Finally, in our study, the effect of Estim on muscle regeneration was only evaluated in aged 
male mice. Future studies should consider whether the effect would be the different in the case of 
aged female mice. Indeed, Deasy et al. (2007) demonstrated that MPCs display sexual 
dimorphism, and that female mice display an enhanced regenerative potential when compared to 
male counterparts, owing to an increased resistance to oxidative stress (144). To the best of our 
knowledge, there are no studies that have investigated the role of sex on declines on MPC 
regenerative capacity over time.   
2.6 CONCLUSION 
Though aging is generally associated with a decreased healing response after injury, these age-
related effects are clearly reversible. Our findings suggest that mechanical loading may restore 
the metabolic activity of MPCs and exert a beneficial effect on progenitor cell fate through an 
inhibition of Wnt signaling activation and cellular senescence. Moreover, we provide evidence to 
suggest that the beneficial effect of Estim on inhibition of cellular senescence may be attributed 
to an increased expression of the longevity protein, Klotho. Future studies are needed to further 
elucidate the mechanisms by which Klotho expression in MPCs is reduced with aging, as well as 
the role of muscle loading as a potential treatment to retard declines in skeletal muscle vitality.
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3.0  SIGNIFICANCE AND DIRECTION OF FUTURE RESEARCH 
The results presented here demonstrate that muscle contractile activity, administered via Estim, 
may be an effective method to promote tissue healing after injury in a geriatric population. Estim 
is often used in the clinic to promote muscle hypertrophy and healing after injury. However, a 
thorough understanding of how Estim may regulate molecular mechanisms to enhance MPC 
function in an elderly population has heretofore been lacking.  
This study investigated the ability of Estim to reverse age-related declines in the skeletal 
muscle healing and function through improved MPC regenerative potential. Specifically, we 
provided evidence to suggest that Estim enhances MPC myogenicity, and that this enhanced 
myogenicity is concomitant with a decreased Wnt/β-Catenin activation and cellular senescence. 
Although previous studies have demonstrated the mechanosensitivity of the Wnt signaling 
pathway by myogenic cell populations, these studies were primarily conducted using young animal 
models in which Wnt signaling occurs at physiological levels (82, 145). Here, we show that a low-
intensity Estim protocol restores Wnt signaling activation to the physiological levels found in 
young counterparts. This decreased Wnt signaling activation following Estim was concomitant 
with a decreased expression of senescent markers in aged MPCs, further confirming a restoration 
of a MPC young phenotype. Still unclear is whether there is a direct relationship between Wnt 
signaling activation and cellular senescence in MPC populations. Moreover, to the best of our 
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knowledge, our study is the first to suggest that MPC senescence may be regulated by mechanical 
stimulation. 
Our data suggest that the decreased cellular senescence following Estim may be attributed 
to an increased expression of the longevity protein, Klotho.  Klotho has been detected in the 
circulatory system in both animals and humans, and has been shown to play a role in the attenuation 
of an aging phenotype (33). Epidemiological studies have demonstrated a strong relationship 
between plasma Klotho expression and skeletal muscle strength and functioning (86, 146). Semba 
and colleagues related plasma Klotho levels with grip strength in 805 adults greater than 65 years 
old, and they found that decreased grip strength was associated with lower plasma Klotho levels 
(86). Another study by Semba and colleagues measured plasma Klotho and knee extension 
strength in 2734 aged adults (71-80 years old) (146). They observed that older adults with higher 
baseline levels of plasma Klotho presented a more gradual decline in knee strength over time, 
when compared to those with lower baseline level of Klotho. These findings support the hypothesis 
that there is a strong relationship between Klotho expression and skeletal muscle vitality. However, 
our study is the first to suggest that Klotho expression may be critical for skeletal muscle 
regeneration and may be modulated by skeletal muscle contractile activity.  
Following an acute muscle injury in young animals, we observed a significant increase in 
local Klotho expression at the site of acutely injured young skeletal muscle, but that this response 
is markedly attenuated with increasing age. Intriguingly, local expression was restored to youthful 
levels with the application of just two weeks of Estim. Still unclear is whether an increased local 
expression of Klotho within the injured muscle is concomitant with an increase in circulating 
Klotho levels. Avin et al recently provided preliminary evidence to suggest that, indeed, circulating 
Klotho levels are upregulated following an acute exercise bout (33). Specifically, young and old 
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animals trained for 45 min on the treadmill running and immediately after exercise, display an 
increase in circulating Klotho levels (85). Taken together, an interesting direction of future research 
would be to explore whether evaluation of circulating Klotho levels may be useful as a predictive 
biomarker of muscle healing capacity. If so, might Estim be indicated to enhance Klotho expression 
in cases where baseline levels suggest a less-than-optimal healing response? (147, 148).  
Recent murine investigations have demonstrated the health benefits of increased 
circulating Klotho levels, and genetic overexpression of Klotho in mice results in a significantly 
improved healthspan and lifespan (65, 66, 149). Our findings that muscle contractile activity 
enhances Klotho expression may shed insight into a potential mechanism by which exercise has 
been shown to confer systemic anti-aging effects, such as on cognitive or cardiovascular 
functioning. As an example, exercise has been shown to reverse age-related declines in cognition, 
and to promote neurogenesis in the brain (150, 151). Recently a study from Dubal and colleagues 
demonstrated that increased levels of Klotho similarly improve synaptic and cognitive functions 
in human amyloid precursor protein (hAPP) transgenic mice (which simulate phenotypes 
characteristic of Alzheimer’s disease). The results suggested that Klotho administration might be 
a promising treatment for Alzheimer’s disease (151). This raises the intriguing question, could the 
beneficial effect of exercise on brain health be mediated by up regulation of Klotho?  
Exercise also has well-established benefits in the preservation of cardiovascular function 
(152, 153). Likewise, Klotho is inversely related to cardiovascular pathology. Studies have 
demonstrated that absence of Klotho in murine models causes atherosclerosis, vascular 
calcification, and defects in angiogenesis, all of which are reversed by Klotho administration (154-
157). Could exercise-induced increases in Klotho play a role in the beneficial effects of exercise 
on cardiovascular functioning?  
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The results of this dissertation study provide novel insights into the association between 
cellular senescence and Klotho in MPCs, as well as the influence of Estim to modulate the 
expression of senescent markers in aged MPCs. Although, muscle contractile activity and Klotho 
expression represents a fascinating relationship that may help us better understand the anti-aging 
effects of exercise, further investigations are necessary to better understand the molecular basis for 
these interactions. For example, it would be interesting to further explore the relationship of 
different age-associated pathways, such as Notch, Transforming Growth Factor Beta (TGFβ-1), and 
Mitogen-Activated Protein Kinase (MAPK), and how these may be regulated by Klotho expression 
in MPCs. A better understanding of Klotho signaling pathway may reveal a new understanding of 
aging declines and aging-related disease. 
More broadly, these findings demonstrate that Estim may be a useful modality to increase 
stem cell regenerative potential, even while still within their native niche, and these results speak 
to the ability of rehabilitation modalities to tap into the intrinsic regenerative potential of resident 
stem cells. Of course, this study also brings new questions and new ideas to the forefront, and paves 
the way for cellular- and molecular-based investigations to guide clinical rehabilitation protocols. 
Despite the promising results, it should be noted that the Estim protocol used in this study was not 
optimized, and it is possible that a protocol with long duration or different intensity would further 
enhance the benefit of Estim on aged muscle healing capacity. Moreover, there are controversies in 
the literature related to the parameters and protocols of Estim used and the ability of murine 
responses to effectively mimic responses observed in humans. This potential disconnect may create 
confusion and a lack of general agreement regarding to specific parameters necessary for each 
specific pathology or treatment. Further translational studies investigating Estim protocol 
refinement are needed to determine the ability of Estim to enhance regeneration in a clinical setting.  
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Taken together, this study brings to light an important and needed intersection between the 
fields of rehabilitation and regenerative medicine. The results collected here suggest that Estim can 
be applied to people and modulates similar factors associated with physical exercise, and attenuates 
the functional decline with aging by improving muscle strength, activating satellite cells, and, 
finally, regulating muscle progenitor cell regenerative potential. We anticipate that these findings 
will be useful in the design of effective and novel therapeutic strategies to counteract aged skeletal 
muscle declines. 
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APPENDIX A 
COMPLEMENTARY TABLES 
Table 2 In vivo outcomes 
 
Values are Mean±SEM. Abbreviations: TNF (Total Number Fibers), CSA (Cross Sectional Area), YC (Young 
Control), YI (Young Injury), AC (Aged Control), AI (Aged Injury), and AEI (Aged Estim Injury) 
 
Table 3 In vitro outcomes 
 
Values are Mean±SEM. Abbreviations: YC (Young Control), AC (Aged Control), and AE (Aged Estim) 
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